Ultrasound-Delivered pain gel shows promise for carpal tunnel sufferers

NCT ID NCT07613476

Ongoing Symptom relief Sponsor: University of Faisalabad Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a pain-relief gel (pregabalin) delivered through the skin using ultrasound can reduce pain and improve hand function in people with carpal tunnel syndrome. The treatment is given four times a week for a month, and compared to standard ultrasound therapy without the drug. The goal is to find a safer, non-invasive option that avoids the side effects of oral medications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: pregabalin gel
What this could lead to: If it works, this could offer a non-invasive, low-side-effect treatment option for carpal tunnel pain and hand function.
What could go wrong: This is a small, early-stage trial with only 30 participants, so results may not apply widely. The treatment may not prove better than standard ultrasound therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARPAL TUNNEL SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

carpal tunnel syndrome neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARPAL TUNNEL SYNDROME (CTS)

Contacts and locations

Locations

The University of Faisalabad

Faisalābad, Punjab Province, 3800, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.